panitumumab [Panitumumab]

tematický
62
Termíny

Vectibix

 

ABX-EGF MAb
ABX-EGF Monoclonal Antibody
Panitumumab Antibody, Human
Vectibix

Perzistentní odkaz   https://www.medvik.cz/link/D000077544
Definice

Recombinant human monoclonal antibody that binds to and inhibits the function of the EPIDERMAL GROWTH FACTOR RECEPTOR. It is used in the treatment of EGFR-expressing metastatic colorectal cancer that expresses wild-type ras gene (see GENES, RAS).

DUI
D000077544 MeSH Prohlížeč
CUI
M0484911
CAS
Immunoglobulin, anti-(human epidermal growth factor receptor) (human monoclonal ABX-EGF heavy chain), disulfide with human monoclonal ABX-EGF light chain, dimer
Historická pozn.
2019 (2005)
Veřejná pozn.
2019; PANITUMUMAB was indexed under ANTIBODIES, MONOCLONAL 2005-2018

D Chemikálie a léčiva
D12.776 proteiny 2 595
D12.776.124 krevní proteiny 911
D12.776.124.486 imunoproteiny 14
D12.776.124.486.485 imunoglobuliny 1 498
D12.776.124.486.485.114 protilátky 1 819
D12.776.124.486.485.114.224 monoklonální protilátky 4 730
D12.776.124.486.485.114.224.060 humanizované monoklonální protilátky 3 003
D12.776.124.486.485.114.224.060.125 abciximab 14
D12.776.124.486.485.114.224.060.250 adalimumab 359
D12.776.124.486.485.114.224.060.313 alemtuzumab 127
D12.776.124.486.485.114.224.060.344 basiliximab 2
D12.776.124.486.485.114.224.060.375 bevacizumab 458
D12.776.124.486.485.114.224.060.438 brentuximab vedotin 45
D12.776.124.486.485.114.224.060.500 certolizumab pegol 50
D12.776.124.486.485.114.224.060.750 cetuximab 186
D12.776.124.486.485.114.224.060.766 daklizumab 6
D12.776.124.486.485.114.224.060.782 denosumab 162
D12.776.124.486.485.114.224.060.790 gemtuzumab 19
D12.776.124.486.485.114.224.060.794 inotuzumab ozogamicin 12
D12.776.124.486.485.114.224.060.798 ipilimumab 271
D12.776.124.486.485.114.224.060.813 natalizumab 160
D12.776.124.486.485.114.224.060.829 nivolumab 468
D12.776.124.486.485.114.224.060.844 omalizumab 117
D12.776.124.486.485.114.224.060.860 palivizumab 14
D12.776.124.486.485.114.224.060.864 panitumumab 62
D12.776.124.486.485.114.224.060.866 ramucirumab 1
D12.776.124.486.485.114.224.060.868 ranibizumab 63
D12.776.124.486.485.114.224.060.875 trastuzumab 280
D12.776.124.486.485.114.224.060.937 ustekinumab 126
D12.776.124.790 sérové globuliny 61
D12.776.124.790.651 imunoglobuliny 1 498
D12.776.124.790.651.114 protilátky 1 819
D12.776.124.790.651.114.224 monoklonální protilátky 4 730
D12.776.124.790.651.114.224.060 humanizované monoklonální protilátky 3 003
D12.776.124.790.651.114.224.060.125 abciximab 14
D12.776.124.790.651.114.224.060.250 adalimumab 359
D12.776.124.790.651.114.224.060.375 alemtuzumab 127
D12.776.124.790.651.114.224.060.407 basiliximab 2
D12.776.124.790.651.114.224.060.438 bevacizumab 458
D12.776.124.790.651.114.224.060.469 brentuximab vedotin 45
D12.776.124.790.651.114.224.060.500 certolizumab pegol 50
D12.776.124.790.651.114.224.060.750 cetuximab 186
D12.776.124.790.651.114.224.060.766 daklizumab 6
D12.776.124.790.651.114.224.060.782 denosumab 162
D12.776.124.790.651.114.224.060.790 gemtuzumab 19
D12.776.124.790.651.114.224.060.794 inotuzumab ozogamicin 12
D12.776.124.790.651.114.224.060.798 ipilimumab 271
D12.776.124.790.651.114.224.060.813 natalizumab 160
D12.776.124.790.651.114.224.060.829 nivolumab 468
D12.776.124.790.651.114.224.060.844 omalizumab 117
D12.776.124.790.651.114.224.060.860 palivizumab 14
D12.776.124.790.651.114.224.060.864 panitumumab 62
D12.776.124.790.651.114.224.060.866 ramucirumab 1
D12.776.124.790.651.114.224.060.868 ranibizumab 63
D12.776.124.790.651.114.224.060.875 trastuzumab 280
D12.776.124.790.651.114.224.060.937 ustekinumab 126
D12.776.377 globuliny 68
D12.776.377.715 sérové globuliny 61
D12.776.377.715.548 imunoglobuliny 1 498
D12.776.377.715.548.114 protilátky 1 819
D12.776.377.715.548.114.224 monoklonální protilátky 4 730
D12.776.377.715.548.114.224.200 humanizované monoklonální protilátky 3 003
D12.776.377.715.548.114.224.200.125 abciximab 14
D12.776.377.715.548.114.224.200.250 adalimumab 359
D12.776.377.715.548.114.224.200.375 alemtuzumab 127
D12.776.377.715.548.114.224.200.407 basiliximab 2
D12.776.377.715.548.114.224.200.438 bevacizumab 458
D12.776.377.715.548.114.224.200.469 brentuximab vedotin 45
D12.776.377.715.548.114.224.200.500 certolizumab pegol 50
D12.776.377.715.548.114.224.200.750 cetuximab 186
D12.776.377.715.548.114.224.200.766 daklizumab 6
D12.776.377.715.548.114.224.200.782 denosumab 162
D12.776.377.715.548.114.224.200.790 gemtuzumab 19
D12.776.377.715.548.114.224.200.794 inotuzumab ozogamicin 12
D12.776.377.715.548.114.224.200.798 ipilimumab 271
D12.776.377.715.548.114.224.200.813 natalizumab 160
D12.776.377.715.548.114.224.200.829 nivolumab 468
D12.776.377.715.548.114.224.200.844 omalizumab 117
D12.776.377.715.548.114.224.200.860 palivizumab 14
D12.776.377.715.548.114.224.200.864 panitumumab 62
D12.776.377.715.548.114.224.200.866 ramucirumab 1
D12.776.377.715.548.114.224.200.868 ranibizumab 63
D12.776.377.715.548.114.224.200.875 trastuzumab 280
D12.776.377.715.548.114.224.200.937 ustekinumab 126